Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sulfacetamide sodium |
Is a |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfacetamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide adverse reaction (disorder) |
Causative agent (attribute) |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to sulfacetamide (finding) |
Causative agent (attribute) |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide 30% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide 20% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide 2.5% eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide 6% eye ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide 15% ophthalmic drop |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide 10% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfabenzamide+sulfacetamide+sulfathiazole 3.7%/2.86%/3.42% vaginal cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 0.2%wv/10%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 5mg/100mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfabenzamide + sulfacetamide + sulfathiazole 184mg/143.75mg/172.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfabenzamide + sulfacetamide + sulfathiazole 3.7%ww/2.86%ww/3.42%ww cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorometholone + sulfacetamide sodium 0.1%wv/10%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Prednisolone acetate + sulfacetamide sodium 0.5%ww/10%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfacetamide in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfacetamide in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfacetamide in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to sulfacetamide (finding) |
Causative agent (attribute) |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium |
Is modification of (attribute) |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfacetamide in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing sulfacetamide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sulfacetamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only sulfacetamide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sulfacetamide in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfabenzamide- and sulfacetamide- and sulfathiazole-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Prednisolone- and sulfacetamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only prednisolone and sulfacetamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Prednisolone- and sulfacetamide-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Prednisolone and sulfacetamide only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sulfabenzamide and sulfacetamide and sulfathiazole only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluorometholone- and sulfacetamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only fluorometholone and sulfacetamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluorometholone- and sulfacetamide-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluorometholone and sulfacetamide only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Bacitracin- and neomycin- and sulfacetamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin and neomycin and sulfacetamide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfacetamide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |